Clinical vitamin B 12 deficiency can result in megaloblastic anemia, which results from the inhibition of DNA synthesis by trapping folate cofactors in the form of 5-methyltetrahydrofolate (5-methylTHF) and subsequent inhibition of de novo thymidylate (dTMP) biosynthesis. In the cytosol, vitamin B 12 functions in the remethylation of homocysteine to methionine, which regenerates THF from 5-methylTHF. In the nucleus, THF is required for de novo dTMP biosynthesis, but it is not understood how 5-methylTHF accumulation in the cytosol impairs nuclear dTMP biosynthesis. The impact of vitamin B 12 depletion on nuclear de novo dTMP biosynthesis was investigated in methionine synthase-null human fibroblast and nitrous oxide-treated HeLa cell models. The nucleus was the most sensitive cellular compartment to 5-methylTHF accumulation, with levels increasing greater than fourfold. Vitamin B 12 depletion decreased de novo dTMP biosynthesis capacity by 5-35%, whereas de novo purine synthesis, which occurs in the cytosol, was not affected. Phosphorylated histone H2AX (γH2AX), a marker of DNA double-strand breaks, was increased in vitamin B 12 depletion, and this effect was exacerbated by folate depletion. These studies also revealed that 5-formylTHF, a slow, tight-binding inhibitor of serine hydroxymethyltransferase (SHMT), was enriched in nuclei, accounting for 35% of folate cofactors, explaining previous observations that nuclear SHMT is not a robust source of onecarbons for de novo dTMP biosynthesis. These findings indicate that a nuclear 5-methylTHF trap occurs in vitamin B 12 depletion, which suppresses de novo dTMP biosynthesis and causes DNA damage, accounting for the pathophysiology of megaloblastic anemia observed in vitamin B 12 and folate deficiency.
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vitamin B 12 | folate | methyl trap | thymidylate | genome instability V itamin B 12 (cobalamin) deficiency disproportionately affects older adults and pregnant women (1) . It can arise from inadequate dietary intake or impaired absorption, with the latter accounting for the majority of cases in developed countries (2, 3) . Vitamin B 12 is essential for maintaining nervous system function as well as hematopoiesis, as the classic sequelae of deficiency include irreversible neurological damage and/or reversible hematological changes (2, 4) . The clinical manifestations of vitamin B 12 deficiency have been known for decades, and it is known that high levels of folate intake can mask megaloblastic anemia (5) , indicating that increased intracellular folate levels can rescue some metabolic consequences of vitamin B 12 deficiency. Conversely, data from cross-sectional studies suggest that low vitamin B 12 and elevated folate status exacerbate symptoms of cognition and anemia (6, 7) as well as biochemical indicators of vitamin B 12 deficiency (7, 8) ; however, there is no mechanistic understanding to support these observations.
There are two enzymes that require vitamin B 12 as a cofactor in mammals: methionine synthase (MTR), which functions in the cytosol, and L-methylmalonyl-CoA (coA) mutase (MUT), which functions in the mitochondria (4). MTR is both vitamin B 12 and folate dependent and catalyzes the conversion of homocysteine to methionine in a two-step process. In the first step, the methyl group from 5-methyltetrahydrofolate (5-methylTHF) is transferred to cobalamin, thereby creating methylcobalamin and releasing THF. In the second step, the methyl group from methylcobalamin is transferred to homocysteine for methionine synthesis (4). Consequences of reduced MTR activity include elevated homocysteine in tissue and plasma, a biomarker associated with adverse health outcomes, including risk for neural tube defects (NTDs) (9) and impaired methylation status, as methionine is required for the synthesis of S-adenosylmethionine (AdoMet), the universal methyl donor required for over 100 cellular methylation reactions (10) . Reduced MTR activity also leads to the trapping of cellular folate as 5-methylTHF, as the methylenetetrahydrofolate reductase (MTHFR)-catalyzed conversion of 5,10-methyleneTHF to 5-methylTHF is irreversible in vivo ( Fig. 1) (11) . The "5-methylTHF trap" is associated with the onset of megaloblastic anemia, which is characterized by erythroid precursors with enlarged cytosol, immature nuclei, and incomplete DNA replication and cell division due to inadequate de novo thymidylate (dTMP) biosynthesis ( Fig. 1) (2, 5, 12) .
The proposed mechanisms underlying vitamin B 12 deficiencyinduced megaloblastic anemia are based on an assumption that both the homocysteine remethylation and de novo dTMP biosynthesis pathways function in the cytosol (13, 14) . However, there is increasing evidence that de novo dTMP biosynthesis occurs in the nucleus at sites of DNA synthesis (15) . The enzymes that participate in de novo dTMP biosynthesis, serine hydroxymethyltransferase 1 and 2α (SHMT1, SHMT2α), dihydrofolate reductase (DHFR), methylenetetrahydrofolate dehydrogenase 1 (MTHFD1), and thymidylate synthase (TYMS) Significance Vitamin B 12 deficiency causes hematological and neurological pathologies by impairing DNA synthesis. The nucleus is shown to be highly sensitive to 5-methyltetrahydrofolate (5-methylTHF) accumulation induced by vitamin B 12 depletion in the cytosol, leading to impaired nuclear de novo thymidylate synthesis and genome instability. These effects of the 5-methylTHF trap are exacerbated by folate depletion in nitrous oxide-treated HeLa cells and methionine synthase loss-of-function fibroblasts. These results further our understanding of mechanisms underlying vitamin B 12 -folate interrelationships in pathologies, including megaloblastic anemia and potentially neural tube defects.
undergo modification by the small ubiquitin-like modifier (SUMO) protein, and translocate to the nucleus where they form a complex at sites of DNA replication and repair ( Fig. 1) during S phase or in response to DNA damage (15) (16) (17) (18) . SHMT serves as an essential scaffold protein that connects this multienzyme complex to the nuclear lamina (15), but does not serve as a primary source of one-carbon units, as most one-carbons incorporated into dTMP are derived from formate via MTHFD1 (19) . TYMS methylates deoxyuridylate (dUMP) using 5,10-methyleneTHF as the cofactor to produce dTMP and dihydrofolate (DHF). DHF is reduced to THF by DHFR, which is NADPH dependent (Fig. 1) . Insufficient concentrations of intracellular folate or impairments in nuclear localization of the de novo dTMP biosynthesis complex can lead to elevated uracil levels in DNA (20, 21) . Low intracellular vitamin B 12 concentrations and/ or status can increase markers of genome instability, including chromosomal abnormalities (22, 23) , DNA strand breaks (24) , and uracil content in DNA (25, 26) . The mechanisms underlying the interactions between folate and vitamin B 12 in maintaining genome stability, and their contributions to human disease, are unresolved. There is evidence that the cytosolic and nuclear folate cofactor pools are distinct. Unlike the cytosol, the nucleus is resistant to folate depletion when total cellular folates are depleted (27) . Therefore, it is not clear whether an accumulation of 5-methylTHF in the cytosol during vitamin B 12 depletion influences folate cofactor pools in the nucleus.
We investigated the impact of vitamin B 12 depletion on nuclear dTMP synthesis in two models of vitamin B 12 deficiency: human fibroblasts with loss-of-function mutations in MTR that comprise the inborn errors of cobalamin metabolism complementation group G (cblG) (28) , and HeLa cells treated with nitrous oxide (N 2 O). The nucleus was observed to be highly sensitive to 5-methylTHF accumulation in vitamin B 12 depletion, which led to depressed rates of de novo dTMP biosynthesis and Otherwise, serine and glycine are converted to formate in mitochondria, which traverses to the cytosol and nucleus where it is condensed with THF by MTHFD1. One-carbon metabolism in the cytosol includes the de novo synthesis of purines and the remethylation of homocysteine to methionine. Vitamin B 12 is a required cofactor for MTR. De novo dTMP biosynthesis occurs in the nucleus, catalyzed by the enzymes SHMT1, SHMT2α, TYMS, and DHFR, which undergo SUMOylation leading to nuclear import in S phase. The 5,10-methyleneTHF is synthesized by SHMT or MTHFD1 for de novo dTMP synthesis. AdoHcy, S-adenosylhomocysteine; AdoMet, S-adenosylmethionine; AICAR Tfase, aminoimidazolecarboxamide ribonucleotide transformylase; DHF, dihydrofolate; DHFR, dihydrofolate reductase; GAR Tfase, glycinamide ribonucleotide tranformylase; MTHFD1, methylenetetrahydrofolate dehydrogenase 1; MTHFS, methenyltetrahydrofolate synthetase; MTHFR, methylenetetrahydrofolate reductase; MTR, methionine synthase; SHMT, serine hydroxymethyltransferase; SUMO, small ubiquitin-like modifier; THF, tetrahydrofolate; and TYMS, thymidylate synthase. increased genome instability. We also demonstrate that the nucleus is enriched in 5-formylTHF cofactors, which are slow, tightbinding inhibitors of SHMT (29) . This observation accounts for the lack of nuclear SHMT catalytic activity in de novo dTMP biosynthesis. These findings link vitamin B 12 depletion to nuclear 5-methylTHF accumulation, impaired DNA synthesis, and genome instability, and provide a mechanism underpinning vitamin B 12 -associated pathologies. (Fig. 3, 1 , B-E vs. 3, B-E). This effect was exacerbated by folate depletion (Fig. 3, 1 , B-E vs. 4, B-E). Importantly, the difference in the percentage of cells with high γH2AX immunostaining between vitamin B 12 -depleted conditions was statistically significant (Fig. 3, 3 , B-E vs. 4, B-E) (SI Appendix, Table S1 , row 5 SI Appendix). Within treatment conditions, the greatest increase in the percentage of cells with high γH2AX immunostaining was observed during G2/M (Fig. 3, 1-4 
, E).
Folate Depletion, but Not MTR Loss of Function, Increases DNA Damage in Human Fibroblasts. In fibroblasts, folate depletion significantly increased γH2AX immunostaining, as quantified by the percentage of nuclear area with γH2AX (P < 0.0001) (Fig.  4A) . MTR loss of function did not significantly affect γH2AX levels when comparing cblG (WG4215 and WG4460) and control fibroblast lines (MCH058 and MCH064) cultured under either folate-replete or depleted culture conditions (P > 0.05) (Fig. 4A) .
Vitamin B 12 and Folate Depletion Impair de Novo dTMP Biosynthesis.
In HeLa cells, vitamin B 12 depletion impaired de novo dTMP synthesis by 5% compared with vitamin B 12 -replete cells (P = 0.02) (Fig. 4B) . A combined folate and vitamin B 12 depletion decreased de novo dTMP capacity by 35% (P < 0.0001). In cblG fibroblasts, MTR loss of function decreased the relative rate of de novo dTMP synthesis by ∼25% (P < 0.0001) (Fig. 4C ).
MTR Loss of Function and Folate Depletion Do Not Impair de Novo
Purine Biosynthesis. Intracellular folate depletion did not significantly impair de novo purine biosynthesis in human fibroblasts (P > 0.05). One control and two cblG cell lines exhibited similar rates of de novo purine biosynthesis, as determined by the ratio of Fig. S1 ). In A-C, statistical significance is denoted as follows: NS, not significant (P > 0.05); *P = 0.01 < P < 0.05; **P = 0.01 < P < 0.001; ***P < 0.001. Fig. S5A) . The difference between vitamin B 12 -depleted conditions was significant (P = 0.002) (SI Appendix, Fig. S5A ). These findings indicate that vitamin B 12 depletion and folate-replete conditions decrease the contribution of SHMTderived single carbons (CD2) compared with folate-and vitamin B 12 -depleted conditions. There was no difference in the CD1/(CD1+CD2) ratio between cblG (WG4215 and WG4460) and control (058MCH and MCH064) fibroblasts cultured in folate-replete conditions (SI Appendix, Fig. S5B ). Table S1 ). The greatest percentage of cells with high γH2AX within conditions was observed in G2/M under vitamin B 12 -and folate-depleted conditions (P < 0.001; 4, E). The vitamin B 12 -depleted and folate-replete condition in row 3 contains duplicate measurements. The experiment was performed twice (SI Appendix, Fig. S3 ). Folate-replete, 25 nM (6S) 5-formylTHF in culture media; folate-depleted, 5 nM (6S) 5-formylTHF in culture media. The statistical significance is represented as follows: NS, not significant (P > 0.05); *P = 0.01 < P < 0.05; **P = 0.01 < P < 0.001; ***P < 0.001.
Discussion
work was motivated by recent findings that the de novo dTMP biosynthesis pathway is present in the nucleus during S phase of the cell cycle and forms a complex at sites of DNA replication and repair (15, 17, 30) . SHMT serves as an essential scaffold for the assembly of this complex but makes only minor contributions as a source of one-carbon units for dTMP synthesis (15, 19) . Proper assembly of the metabolic complex and adequate levels of THF cofactors in the nucleus are required to maintain adequate dTMP synthesis and genome integrity (20, 21) . Mice with reduced Shmt1 expression exhibit 2.5-to 4.5-fold elevations in levels of uracil in nuclear DNA (31) , and elevated levels of uracil incorporation into DNA result in loss of DNA integrity (21) . This study demonstrates that vitamin B 12 depletion in HeLa cells traps nuclear folate as 5-methylTHF, impairs rates of de novo dTMP biosynthesis, and leads to genome instability. These effects of vitamin B 12 depletion were exacerbated by folate depletion. In vitamin B 12 -depleted HeLa cells, the elevations in 5-methylTHF were more pronounced in nuclei compared with whole cells, with a greater than fourfold increase in nuclear 5-methylTHF (Fig. 2 B and C) . The sensitivity of the nucleus to 5-methylTHF accumulation is striking, given that 5-methylTHF is synthesized in the cytosol. CblG fibroblasts, which lack MTR activity, exhibit elevated levels of 5-methylTHF compared with control fibroblasts, and therefore serve as a model of severe vitamin B 12 depletion (Fig. 2A) . Loss of MTR activity seen in cblG fibroblasts was also associated with reduced de novo dTMP biosynthesis capacity compared with control fibroblasts (Fig.  4C) . In contrast to HeLa cells, the reduction in de novo dTMP biosynthesis did not result in elevations in γH2AX immunostaining (Fig. 4A) in MTR loss-of-function fibroblasts.
The effect of impaired de novo dTMP biosynthesis on increasing genome instability as evidenced by increased γH2AX immunostaining could result from two potential mechanisms. γH2AX levels may increase as a result of reduced replication fork movement (32) or due to base excision repair pathways that remove uracil from DNA (33) . Reduced replication fork movement has been reported in lymphocytes from patients with megaloblastic anemia (34) . When stratified by cell cycle, the γH2AX immunostaining observed as a result of vitamin B 12 and folate depletion occurred primarily during S phase and G2/M phase of the cell cycle (Fig. 3) . The presence of a stalled replication fork may be responsible for the increased γH2AX immunostaining that is observed during S phase, as vitamin B 12 depletion decreases the amount of nuclear THF available for subsequent nucleotide biosynthesis (Figs. 2C and 4 B and C) . Alternatively, it is possible that the DSBs observed in S and G2/M phases of the cell cycle may arise as a result of base-excision repair of genomic uracil in DNA (33) . In HeLa cells, folate depletion exacerbated genome instability associated with vitamin B 12 depletion, with high rates of genome instability observed in all phases of the cell cycle, including G1 phase (Fig. 3, 4 , B-E). Our findings are in contrast to observational studies reporting that high folate status worsens clinical symptoms (6, 7) and biochemical indicators of vitamin B 12 deficiency (7, 8) .
This study provides a role for 5-formylTHF in de novo dTMP synthesis, as it revealed that nuclear folate pools are enriched in 5-formylTHF. The role of 5-formylTHF in mammalian one-carbon metabolism has been elusive. It does not serve as a metabolic cofactor, but rather has been proposed to serve as a stable, storage form of folate, and is an inhibitor of folate-dependent enzymes, including SHMT (35) . SHMT and MTHFS participate in a futile cycle that regulates cellular 5-formylTHF levels. SHMT synthesizes 5-formyTHF, whereas MTHFS converts 5-formylTHF back to a metabolically active cofactor (Fig. 1 ) (36) . Five-formylTHF is a minor component of the total cellular folate pool (8%), but accounts for 35% in nuclei. The enrichment of 5-formylTHF in HeLa nuclei provides a mechanism for previous observations that the majority of one-carbon units incorporated into dTMP are derived from formate via MTHFD1 and not from serine via SHMT1 and/or SHMT2α (Fig. 1) (16, 19) . The 5-formylTHF present in the nucleus is expected to inhibit SHMT1 and SHMT2α, as 5-formylTHF is a slow, tight-binding inhibitor of SHMT (29) . The increase in incorporation of onecarbons from MTHFD1 into dTMP in folate-replete and vitamin B 12 -deficient HeLa cells is likely explained by the increased pool of 5-methylTHF, which also binds and inhibits SHMT (SI Appendix, Fig. S5A ) (29) . It is unclear whether nuclear SHMT activity and, hence, de novo dTMP biosynthesis is regulated by changes in nuclear 5-formylTHF levels. This study provides a mechanism whereby vitamin B 12 depletion in the cytosol impairs de novo dTMP synthesis in the nucleus by trapping folate as 5-methylTHF. These studies were performed in cell culture model systems because of the challenges of measuring one-carbon metabolic pathways in humans and animal models in vitamin B 12 deficiency. However, these findings extend our understanding of vitamin B 12 -associated human pathologies and inform the design of experiments in in vivo model systems. Megaloblastic anemia is characterized by impaired maturation and proliferation of red blood cell precursors during hematopoiesis that results in an accumulation of cells in S phase, as the G2-to-M transition cannot be completed for cell division because of inadequate THF pools (2) . Furthermore, maternal vitamin B 12 deficiency has been associated with NTDs (37) (38) (39) . NTDs arise when the neural folds fail to fuse entirely during neurulation in early embryogenesis, a period of rapid growth that places demands on nucleotide pools for the cell division required to complete neural tube closure. Folic acid supplementation reduces the occurrence and recurrence of NTDs by up to 70% (40, 41) . Impairments in de novo dTMP synthesis, have been implicated in the etiology of folate-responsive NTDs, both in human studies and in animal models (42) (43) (44) . The role of a nuclear 5-methylTHF trap resulting from vitamin B 12 depletion in neural tube closure warrants further investigation.
Materials and Methods
Cell Culture. Two patient [WG4215 and WG4460 cblG (MTR loss of function)] and two MCH control fibroblast cell lines (MCH058 and MCH064) were maintained in MEM, α-modification (α-MEM; HyClone) supplemented with 10% (vol/vol) FBS (HyClone) and 1× penicillin-streptomycin (Mediatech). The WG4460 cells were derived from an 11-mo-old female patient and the molecular cause of the MTR deficiency is unknown. WG4215 cells were derived from a 6-mo-old female patient, and though these cells lack MTR activity, the causal mutation has not been characterized. The MCH058 and MCH064 control fibroblast cell lines were derived from healthy male patients aged 3 and 2 mo, respectively. For all analyses, control cell lines were used between passage 9 and 13 and cblG fibroblast cell lines were used at passages [14] [15] [16] [17] [18] . For all studies, cells were maintained in custom-defined media (HyClone, no. SH3A4302.01) with 10% (vol/vol) dialyzed FBS (3 kDa molecular weight pore size) (HyClone). Culture medium contained 2 mM glycine (MP Biomedicals), 1 mg/L pyridoxine (Sigma), 250 μM methionine (Sigma), 1.35 μM cyanocobalamin (vitamin B 12 replete, Sigma), and either 5 nM (6S) 5-formylTHF (folate deplete) or 25 nM (6S) 5-formylTHF (folate replete) (Schircks Laboratories). N 2 O-Induced Inactivation of MTR. To inactivate MTR activity, HeLa cells were placed in a hypoxia incubator chamber (Stemcell Technologies) and treated with a N 2 O gas mixture consisting of 50% N 2 O, 45% balance air, and 5% CO 2 (Airgas). At time 0, the N 2 O gas mixture was delivered to the chamber at 20 psi for 5 min according to manufacturer's instructions, and this step was repeated 1 h later; the chamber was flushed with the N 2 O gas mixture for 5 min twice every 24 h. Before initiating treatment with N 2 O, culture medium on appropriate plates was replaced with culture medium purged with N 2 O for 5 min, and fresh media was administered to plates that did not undergo N 2 O treatment. Biochemicals) . Following a 24-h incubation, 7 mL of vitamin B 12 -replete or -depleted medium purged with N 2 O gas was added to the appropriate plates, which were cultured for 24 h in the hypoxia chamber. Cell monolayers were washed, harvested, and intracellular folates were extracted as previously described (45) . Fibroblasts were cultured with labeled folates as described elsewhere (45) . Folate one-carbon forms were separated and quantified using reverse-phase HPLC as previously described (46) . and then maintained as previously described for another 48 h. Nuclei were extracted using the REAP method (47). The nuclear pellet was resuspended in 200 μL folate extraction buffer (45) and sonicated twice using a Branson Sonifier 150 on level V3 for 5 s on ice. Folate one-carbon forms were separated and quantified using reverse-phase HPLC as previously described (46) .
Immunoblotting. Proteins (20 μg per lane) were separated on a 4-20% (vol/vol) SDS/PAGE gel (Novex) and transferred onto Immobilon-P PVDF membranes (Millipore). Membranes were blocked overnight in 5% (wt/vol) BSA (Sigma) in PBS with 0.2% Tween-20 (Amresco) and 0.02% sodium azide (Sigma). Fulllength α-tubulin protein (52 kDa) was detected using mouse anti-human monoclonal primary antibody (mAb) at 1:1,000 dilution (Active Motif), and a 1:10,000 dilution of HRP-conjugated goat anti-mouse secondary antibody (Pierce). Full-length Lamin B1 protein (68 kDa) was detected using a rabbit anti-human monoclonal antibody (Cell Signaling) at 1:1,000 dilution and a 1:5,000 dilution of HRP-conjugated donkey anti-rabbit secondary (Pierce). Secondary antibodies were incubated in 10% (wt/vol) nonfat dry milk in PBS and 0.1% Nonidet P-40 (US Biologicals). The membranes were incubated in SuperSignal West Pico Chemiluminescent Substrate (Pierce) and exposed to autoradiography. O treatment groups were returned to the chamber and exposed to N 2 O gas mixture for an additional 48 h. Cells were harvested and genomic DNA was extracted with a DNA Isolation Kit for Cells and Tissues (Roche). The radioisotope quantification was performed as described previously (48) . Statistical analyses were performed on HeLa cell data using a Student's two-tailed t test. Significance in fibroblasts was assessed using two-way ANOVA in JMP Pro-12 Software (SAS). Independent variables were fibroblast genotype, vitamin B 12 (replete or depleted), and the interaction term; the dependent variable was the ratio of 14 C-dU to 3 H-thymidine in nuclear DNA.
Quantification of γH2AX by Flow Cytometry. The impact of vitamin B 12 and/or folate depletion on γH2AX formation in HeLa cells was assessed using flow cytometry (49) . Briefly, cells (1 × 10 6 ) were seeded in 10-cm plates in modified media supplemented with folate and/or cyanocobalamin. Vitamin B 12 depletion was induced with the N 2 O gas mixture at 24-h postplating and held for 48 h. Cells were reseeded at a 1:5 density in triplicate and treated with N 2 O gas mixture for an additional 48 h. One aliquot of cells per treatment group was saved at harvest for the microbiological assay to quantify intracellular folate. For the positive control. A total of 100 μM etoposide (Sigma) was added to culture medium in the positive control plate for 1 h before trypsinizing cells. For preparation of all samples. Cells were washed twice with 1× PBS and harvested with 1× trypsin-EDTA for no longer than 5 min. Cells were pelleted at 500 × g for 4 min at room temperature. Cell pellets were washed once with PBS before a final centrifugation. The supernatant was discarded, and pellets were incubated on ice until staining. γH2AX staining. A total of 150 μL of master mix containing Block-9 buffer, FITC-conjugated α-γH2AX antibody (1:3,000; Millipore), and Vybrant Violet DNA stain (1:1,000; Life Sciences) was added to each sample. Cell pellets were gently resuspended by vortexing and incubated on ice in the dark for 3 h. Samples were resuspended 1× PBS and strained immediately before each analysis. The samples were analyzed on a BD FACSAria flow cytometer using 488-and 405-nm lasers for excitation of FITC and Vybrant Violet Dye Cycle Stain, respectively. Data were recorded for ∼200,000 events per replicate, and initial gating excluded any debris and clumped cells. This population was further gated to exclude those cells with a large area and width to obtain the parent gated population for γH2AX analyses.
